tiprankstipranks
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Cash flow

Compare
1,352 Followers

Beam Therapeutics Cash Flow

BEAM's free cash flow for Q3 2024 was $-89.70M. For the 2024 fiscal year, BEAM's free cash flow was decreased by $-156.50M and operating cash flow was $-88.13M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -149.19M$ 22.53M$ -66.27M$ -95.74M$ -72.00M
Investing Cash Flow
$ 71.84M$ -461.34M$ -294.14M$ -100.12M$ -66.66M
Financing Cash Flow
$ 276.45M$ 111.59M$ 756.14M$ 322.32M$ 41.28M
End Cash Position
$ 444.61M$ 245.52M$ 572.74M$ 177.01M$ 50.55M
Free Cash Flow
$ -182.93M$ -26.42M$ -113.08M$ -112.10M$ -84.52M
Currency in USD

Beam Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis